NewsMarkets

Science

Study Finds Intravenous Apelin Does Not Correct Artificially Induced Hyponatremia

A trial published in Nature Communications shows the drug fails to increase urine output in healthy volunteers with experimentally induced low blood sodium.

1 publisher · 1 article · first seen 16 Oct 2026 · updated 22d ago

Headline and summary written by an AI model from the linked article; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 16 Oct 2026. Nature Communications published first, on 16 October at 00:00 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Intravenous [Pyr¹]apelin-13 in Healthy Volunteers with Artificially-Induced Syndrome of Inappropriate Antidiuresis - a double-blind, randomised, placebo-controlled crossover study Nature Communications ·
Embed this story

Paste this into any web page to show the live odds, with a link back here.